IDEXX Laboratories Inc. (IDXX)
NASDAQ: IDXX
· Real-Time Price · USD
651.27
-2.68 (-0.41%)
At close: Aug 15, 2025, 3:59 PM
650.84
-0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT
IDEXX Laboratories Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 164.59M | 163.97M | 288.27M | 308.64M | 401.59M | 397.43M | 453.93M | 331.7M | 132.84M | 111.37M | 112.55M | 99.18M | 114.36M | 204.62M | 144.45M | 145.2M | 232.13M | 351.16M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 58.3M | 58M | 57.72M | 55.23M | 53.79M | 54.4M | 56.19M | 54.33M | 55.39M | 54.27M | 55.5M | 51.76M | 52.89M | 12.01M | 18.6M | 9.79M | 10.49M | 11.19M |
Other Long-Term Assets | 397.44M | 366.48M | 364.17M | 369.36M | 359.87M | 338M | 332.98M | 325.09M | 318.5M | 309.74M | 307.01M | 299.75M | 305.11M | 300.46M | 287.02M | 282.49M | 268.09M | 255.98M |
Receivables | 663.47M | 604.15M | 561.32M | 587.07M | 608.31M | 578.24M | 529.53M | 521.87M | 532.29M | 519.86M | 490.9M | 452.9M | 473.12M | 465.62M | 425.58M | 425.03M | 427.39M | 423.1M |
Inventory | 392.58M | 395.99M | 381.88M | 389.8M | 379.96M | 390.6M | 380.28M | 393.97M | 395.14M | 391.01M | 367.82M | 354.98M | 332.56M | 301.64M | 269.03M | 258.48M | 241.39M | 225.56M |
Other Current Assets | 95.49M | 100.16M | 109.81M | 91.01M | 92.3M | 88.05M | 83.14M | 86.82M | 79.84M | 87.12M | 88.46M | 112.11M | 86.5M | 76.96M | 74.59M | 71.86M | 67.09M | 63.21M |
Total Current Assets | 1.36B | 1.32B | 1.4B | 1.43B | 1.53B | 1.5B | 1.5B | 1.38B | 1.18B | 1.15B | 1.1B | 1.06B | 1.04B | 1.09B | 955.65M | 938.04M | 1B | 1.1B |
Property-Plant & Equipment | 869.46M | 833.62M | 829.25M | 838.8M | 827.7M | 828.61M | 817.68M | 804.88M | 797.42M | 780.5M | 768.09M | 722.51M | 709.68M | 701.19M | 692.77M | 680.35M | 654.98M | 637.53M |
Goodwill & Intangibles | 518.22M | 514.89M | 516.78M | 518.96M | 518.83M | 524.02M | 450.46M | 448.89M | 455.14M | 457.3M | 459.47M | 455.26M | 456.12M | 466.16M | 458.38M | 450.22M | 450.6M | 296.56M |
Total Long-Term Assets | 1.97B | 1.9B | 1.89B | 1.92B | 1.89B | 1.85B | 1.76B | 1.7B | 1.69B | 1.66B | 1.65B | 1.58B | 1.56B | 1.5B | 1.48B | 1.45B | 1.41B | 1.23B |
Total Assets | 3.33B | 3.21B | 3.29B | 3.35B | 3.41B | 3.35B | 3.26B | 3.09B | 2.87B | 2.81B | 2.75B | 2.64B | 2.61B | 2.59B | 2.44B | 2.39B | 2.41B | 2.33B |
Account Payables | 116.58M | 120.1M | 114.21M | 110.6M | 117.47M | 117.46M | 110.64M | 112.61M | 107.66M | 117.71M | 110.22M | 110.14M | 127.26M | 120.88M | 116.14M | 86.68M | 93.02M | 87.17M |
Deferred Revenue | 36.32M | 35M | 33.8M | 38.43M | 38M | 38.19M | 37.2M | 37.28M | 37.78M | 37.84M | 37.94M | 40.81M | 40.77M | 40.91M | 40.03M | 41.13M | 41.13M | 41.64M |
Short-Term Debt | 653.99M | 490.43M | 417.79M | 349.14M | 420.11M | 325M | 325M | 399.99M | 338.99M | 506.49M | 653.98M | 633M | 611M | 400M | 148.5M | 74.99M | 124.98M | 124.97M |
Other Current Liabilities | 140.92M | 122.23M | 174.58M | 158.99M | 124.02M | 116.34M | 174.38M | 158.16M | 125.6M | 110.84M | 142.99M | 132.15M | 110.34M | 105.92M | 182.93M | 161.58M | 136.33M | 100.16M |
Total Current Liabilities | 1.22B | 1.14B | 1.07B | 1.01B | 1.12B | 956.9M | 951.55M | 970.19M | 883.86M | 1.07B | 1.24B | 1.19B | 1.17B | 971.34M | 763.58M | 633.85M | 651.81M | 620.66M |
Long-Term Debt | 449.81M | 449.8M | 449.79M | 524.76M | 524.74M | 620.78M | 622.88M | 618.81M | 696.84M | 696.36M | 694.39M | 760.81M | 768M | 773.38M | 775.21M | 778.02M | 780.08M | 778.75M |
Other Long-Term Liabilities | 56.79M | 47.73M | 44.34M | 62.88M | 53.4M | 66.26M | 65.53M | 60.21M | 64.28M | 70.86M | 67.59M | 70.95M | 69.78M | 71.85M | 70.94M | 72.99M | 85.04M | 83.55M |
Total Long-Term Liabilities | 648.09M | 629.46M | 630.21M | 723.49M | 717.91M | 827.71M | 823.85M | 818.8M | 893.09M | 901.67M | 902.23M | 974.12M | 983.63M | 981.55M | 983.63M | 996.43M | 1.01B | 1B |
Total Liabilities | 1.87B | 1.77B | 1.7B | 1.73B | 1.83B | 1.78B | 1.78B | 1.79B | 1.78B | 1.97B | 2.14B | 2.16B | 2.15B | 1.95B | 1.75B | 1.63B | 1.66B | 1.62B |
Total Debt | 1.24B | 1.06B | 986.95M | 998.28M | 1.07B | 1.07B | 1.07B | 1.14B | 1.15B | 1.32B | 1.47B | 1.51B | 1.5B | 1.28B | 1.03B | 963.17M | 1.01B | 999.82M |
Common Stock | 10.8M | 10.79M | 10.78M | 10.77M | 10.77M | 10.77M | 10.75M | 10.74M | 10.74M | 10.73M | 10.72M | 10.71M | 10.71M | 10.7M | 10.69M | 10.68M | 10.68M | 10.67M |
Retained Earnings | 5.87B | 5.58B | 5.33B | 5.12B | 4.88B | 4.68B | 4.44B | 4.25B | 4.04B | 3.81B | 3.6B | 3.43B | 3.25B | 3.11B | 2.92B | 2.76B | 2.58B | 2.38B |
Comprehensive Income | -76.95M | -90.09M | -93.64M | -75.97M | -85.18M | -80.4M | -71.21M | -74.89M | -73.67M | -76.61M | -77.8M | -80.89M | -67.7M | -47.35M | -53.48M | -52.06M | -48.39M | -59.54M |
Shareholders Equity | 1.46B | 1.45B | 1.6B | 1.62B | 1.58B | 1.57B | 1.48B | 1.3B | 1.09B | 841.1M | 608.74M | 476M | 457.01M | 639.8M | 689.99M | 754.75M | 747.46M | 702.7M |
Total Investments | 58.3M | 58M | 57.72M | 55.23M | 53.79M | 54.4M | 56.19M | 54.33M | 55.39M | 54.27M | 55.5M | 51.76M | 52.89M | 12.01M | 18.6M | 9.79M | 10.49M | 11.19M |